UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
TRANSMEDICS GROUP, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
|
Your Vote Counts! |
||||||||||
|
|
TRANSMEDICS GROUP, INC.
2024 Annual Meeting Vote by May 22, 2024 11:59 PM ET |
|||||||||
|
TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD, SUITE 302 ANDOVER, MA 01810 |
|
|||||||||
|
| ||||||||||
You invested in TRANSMEDICS GROUP, INC. and it's time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on May 23, 2024.
Get informed before you vote
View the Notice & Proxy Statement, Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 09, 2024. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
| Smartphone users |
|
Vote Virtually at the Meeting* | ||||
|
Point your camera here and |
May 23, 2024 | |||||
| vote without entering a | 8:00 AM EDT | |||||
| control number | ||||||
|
|
Virtually at: www.virtualshareholdermeeting.com/TMDX2024 | |||||
| * | Please check the meeting materials for any special requirements for meeting attendance. |
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.
| Board | ||||||||
| Voting Items | Recommends | |||||||
| 1. | Election of Directors | |||||||
| Nominees: | ||||||||
| 1a. | Waleed Hassanein, M.D. |
For | ||||||
| 1b. | James R. Tobin |
For | ||||||
| 1c. | Edward M. Basile |
For | ||||||
| 1d. | Thomas J. Gunderson |
For | ||||||
| 1e. | Edwin M. Kania, Jr. |
For | ||||||
| 1f. | Stephanie Lovell |
For | ||||||
| 1g. | Merilee Raines |
For | ||||||
| 1h. | David Weill, M.D. |
For | ||||||
| 2. | To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. |
For | ||||||
| 3. | To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2024. |
For | ||||||
| NOTE: Such other business as may properly come before the meeting or any adjournment thereof. | ||||||||
|
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
|